This paper is based on the recognition of a relatively recently described type of thyroid carcinoma.
In 1959, Hazard, Hawk & Crile published a description of 21 examples of a type of tumour which they named medullary carcinoma of the thyroid. It was clearly separable from the three other major types of thyroid carcinoma; in pathological terms, it was solid but not anaplastic, it showed neither papillary nor follicular differentiation, and it contained varying amounts of amyloid in the stroma. This type had been recognized but not as clearly defined before this description, notably by Horn (1951) and Laskowski (1957) .
On further study of this tumour, it became apparent that it was more than a minor pathological subtype. Investigation showed that it is the only type of thyroid carcinoma associated with phaeochromocytoma (Williams 1965) , the only type found in a neurocutaneous syndrome, allied to von Recklinghausen's disease (Williams & Pollock 1966) and probably the only type that is familial. These findings together with the histological differences suggest that it is an entirely distinct entity. In collaboration with Professor I Doniach and Dr C L Brown, I have collected 67 cases. We have studied the pathological features of this tumour, and correlated them with the prognosis . During a survey of the clinical records of these casesand here I must acknowledge my indebtedness to those clinicians who have allowed me access to their filesit became apparent that several of these patients had complained of severe unexplained diarrhcea. A record of this was kept; minor episodes of diarrhoea elicited by questioning were discounted.
Of the 67 cases, adequate records were available for 41; of these 12 were recorded as having severe diarrhoea. The diarrhexa was of the type expected with a simple intestinal hurry. The usual complaint was of passing frequent loose watery motions, sometimes with undigested food, but without blood or mucus. Radiological investigation was carried out on a number of occasions, and in no case was a cause for the diarrhoea demonstrated. In 2 patients the radiologist commented particularly on the intestinal hurry: in one, barium reached the c=cum in half an hour and the rectum in one hour; in the other, the phrase 'terrific intestinal hurry' was used. In 7 cases autopsy examinations were performed, and in only one was any adequate cause for the diarrhoea found.
There was a good correlation between the extent of the tumour and the occurrence of the diarrhoea. While 12 of the 41 patients had diarrhoea, 10 out of 17 with widespread tumour had diarrhoea. Taken together with the lack of any other cause, this suggested that the link between this tumour and the diarrhoea might be humoral.
This was supported by the observation in 4 cases that the diarrhoea improved after resection of tumour. Two of these instances followed resection of massive secondary deposits, one from the neck, the other from the mediastinum. The other 2 followed resection of the primary tumour together with local lymph node deposits.
In 3 of these patients the diarrhoea returned when the patient developed widespread metastases. The suggestion that this tumour may produce a humoral factor leading to diarrhoea has obvious parallels to the carcinoid syndrome. The resemblance is increased by the finding that 4 of the 12 patients were noted to be red-faced, in the absence of any mediastinal obstruction. One had episodic flushing, and volunteered that the flushing was brought on by alcohol. This was before the carcinoid syndrome was established, but it was confirmed on two occasions that alcohol induced an intense flush, lasting about forty minutes. One other patient also stated that his high facial colour was very much increased by alcohol. However, in this case and in another with medullary carcinoma and diarrhoea, the 5hydroxyindole acetic acid (5-HIAA) excretion was normal. Despite this, there are a number of other features suggesting a resemblance between medullary carcinoma of the thyroid and a carcinoid tumour.
In the first place, there is an histological resemblance between medullary carcinoma of the thyroid and carcinoid tumours. Secondly, on the basis of a comparative study of human and animal thyroid carcinomas, I have suggested that medullary carcinoma is a parafollicular cell tumour of the thyroid (Williams 1966) . The parafollicular cell is a second type of thyroid epithelial cell which lies between the follicular epithelium and the basement membranein a situation analogous to that of the Kulchitsky cell. The parafollicular cell in the sheep has been shown by Falck et al. (1964) to contain 5hydroxytryptamine. Thirdly, a single case report of a patient with a 'solid' carcinoma of the thyroid and the carcinoid syndrome has been recorded (Moertel et al. 1965) ; the 5-HIAA excretion was raised. Finally, we have been estimating 5-HIAA excretion in patients with medullary carcinoma. So far one of the 3 patients tested showed an elevated level, 25 mg/24 hours. This patient did not have any diarrhcea.
It has been known for some years that serotonin is not the sole explanation of the carcinoid syndrome, and recent work from Sjoerdsma's laboratory provides evidence that carcinoid tumours contain kallikrein, an enzyme which acts on a globulin substrate to produce bradykinin or other similar vasoactive polypeptides (Oates et al. 1964) . The exact roles played by kinins and by serotonin in the causation of the carcinoid syndrome are not clear, but it is likely that the kinins play a major role. Kinins and serotonin are found together in a number of situations in nature, so that as parafollicular cells can make serotonin, it is likely that they and their tumours are also capable of producing kinins.
In conclusion, I suggest that medullary carcinoma of the thyroid is a tumour allied to the carcinoid group of tumours, and that it may on occasions produce 5-hydroxytryptamine or its precursor, 5-hydroxytryptophan. Patients with widespread medullary carcinoma not infrequently have severe unexplained diarrhoea, and sometimes facial flushing. The most likely explanation for this is the production by the tumour of a kinin polypeptide acting on smooth muscle. Preliminary experiments on an extract of one tumour support this conclusion.
The Conversion of Cortisone to
Cortisol and Prednisone to Prednisolone in Man [Abridged] by J S Jenkins MD MRcP and P A Sampson MB (St George's Hospital, London) In the history of steroid therapy, cortisone occupies the place of first importance but there is now considerable evidence that cortisone itself is biologically inactive. Several investigators (Hollander et al. 1951) have reported that the injection of cortisone locally into inflamed joints is ineffective when compared with cortisol. Jenkins et al. (1964) , studying the effects of steroids on lipid metabolism, showed that the local infusion of cortisol intra-arterially into the forearm was followed by release of free fatty acids into the venous blood but the infusion of cortisone was without effect. Even more striking is the difference in behaviour of the 2-methyl derivatives of cortisol and cortisone when given systemically. 2-methyl cortisol is several times more active than the parent cortisol, whereas 2-methyl cortisone is almost devoid of activity. Bush & Mahesh (1959) showed that this difference was due to the 2-methyl group hindering the reduction of the 1 1-ketone group. It is this reduction of the 1 1-ketone to 11 ,-hydroxyl by the enzyme 11 P-dehydrogenase which renders the 1 1-ketosteroids biologically active when they are administered systemically. Jenkins (1966) has shown from experiments carried out in vitro using human tissues, that the liver was the most important site for this conversion. Other tissues, such as the kidney, which were very active in oxidizing cortisol to cortisone, could not carry out the reduction of the 1 1-ketone. Since steroids having the 1 1-ketone configuration such as cortisone and prednisone are widely used therapeutically it was considered important to study the extent to which they became converted tothe biologically active 11 P-hydroxy compounds.
The Conversion ofCortisone to Cortisol
This was determined by estimating plasma .cortisol levels at hourly intervals after the oral administration of single doses of cortisone; 25 mg was given to each of 3 patients with Addison's disease, and 100 mg or 200 mg to 9 normal subjects. Plasma cortisol was measured specifically in the presence of cortisone by a fluorimetric technique. On separate occasions a similar dose of cortisol was administered to each of the same subjects and the plasma cortisol levels were compared. The peak value in the plasma
